166 related articles for article (PubMed ID: 33021210)
1. Activity of carbonyl cyanide-3-chlorophenylhydrazone on biofilm formation and antimicrobial resistance in Pseudomonas aeruginosa using quantum dots-meropenem conjugates as nanotools.
Silva Júnior VV; Raposo BL; Lopes ACS; Araújo PSR; Fontes A; Cabral Filho PE; Maciel MAV
Methods Appl Fluoresc; 2020 Oct; 8(4):045005. PubMed ID: 33021210
[TBL] [Abstract][Full Text] [Related]
2. Synergistic efficacy of Bisbenzimidazole and Carbonyl Cyanide 3-Chlorophenylhydrazone combination against MDR bacterial strains.
Sinha D; Pandey S; Singh R; Tiwari V; Sad K; Tandon V
Sci Rep; 2017 Mar; 7():44419. PubMed ID: 28303897
[TBL] [Abstract][Full Text] [Related]
3. Effect of the proton motive force inhibitor carbonyl cyanide-m-chlorophenylhydrazone (CCCP) on Pseudomonas aeruginosa biofilm development.
Ikonomidis A; Tsakris A; Kanellopoulou M; Maniatis AN; Pournaras S
Lett Appl Microbiol; 2008 Oct; 47(4):298-302. PubMed ID: 19241523
[TBL] [Abstract][Full Text] [Related]
4. Spread of efflux pump-overexpressing, non-metallo-beta-lactamase-producing, meropenem-resistant but ceftazidime-susceptible Pseudomonas aeruginosa in a region with blaVIM endemicity.
Pournaras S; Maniati M; Spanakis N; Ikonomidis A; Tassios PT; Tsakris A; Legakis NJ; Maniatis AN
J Antimicrob Chemother; 2005 Oct; 56(4):761-4. PubMed ID: 16115825
[TBL] [Abstract][Full Text] [Related]
5. Repurposing approved drugs as potential efflux pump inhibitors in multidrug-resistant
de Melo Guedes GM; Pereira VC; Freitas AS; Honório de Souza PR; Chacon Parra AL; Brasil JA; de Medeiros Guedes RF; Pereira de Sousa PC; Aguiar Cordeiro R; Gadelha Rocha MF; Costa Sidrim JJ; Souza Collares Maia Castelo Branco D
Future Microbiol; 2024; 19(6):495-508. PubMed ID: 38629920
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional Analysis of MexAB-OprM Efflux Pumps System of Pseudomonas aeruginosa and Its Role in Carbapenem Resistance in a Tertiary Referral Hospital in India.
Choudhury D; Das Talukdar A; Dutta Choudhury M; Maurya AP; Paul D; Dhar Chanda D; Chakravorty A; Bhattacharjee A
PLoS One; 2015; 10(7):e0133842. PubMed ID: 26221722
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of efflux pump activity and biofilm formation in multidrug resistant clinical isolates of Pseudomonas aeruginosa isolated from a Federal Medical Center in Nigeria.
Ugwuanyi FC; Ajayi A; Ojo DA; Adeleye AI; Smith SI
Ann Clin Microbiol Antimicrob; 2021 Feb; 20(1):11. PubMed ID: 33531042
[TBL] [Abstract][Full Text] [Related]
8. Spread of Efflux Pump Overexpressing-Mediated Fluoroquinolone Resistance and Multidrug Resistance in Pseudomonas aeruginosa by using an Efflux Pump Inhibitor.
Adabi M; Talebi-Taher M; Arbabi L; Afshar M; Fathizadeh S; Minaeian S; Moghadam-Maragheh N; Majidpour A
Infect Chemother; 2015 Jun; 47(2):98-104. PubMed ID: 26157587
[TBL] [Abstract][Full Text] [Related]
9. Effect of Titanium Dioxide Nanoparticles on the Expression of Efflux Pump and Quorum-Sensing Genes in MDR
Ahmed FY; Aly UF; Abd El-Baky RM; Waly NGFM
Antibiotics (Basel); 2021 May; 10(6):. PubMed ID: 34073802
[TBL] [Abstract][Full Text] [Related]
10. The effect of the efflux pump inhibitor Carbonyl Cyanide m-Chlorophenylhydrazone (CCCP) on the susceptibility to imipenem and cefepime in clinical strains of Acinetobacter baumannii.
Sanchez-Carbonel A; Mondragón B; López-Chegne N; Peña-Tuesta I; Huayan-Dávila G; Blitchtein D; Carrillo-Ng H; Silva-Caso W; Aguilar-Luis MA; Del Valle-Mendoza J
PLoS One; 2021; 16(12):e0259915. PubMed ID: 34919563
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of ceftolozane/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model.
Gómez-Junyent J; Benavent E; Sierra Y; El Haj C; Soldevila L; Torrejón B; Rigo-Bonnin R; Tubau F; Ariza J; Murillo O
Int J Antimicrob Agents; 2019 May; 53(5):612-619. PubMed ID: 30682497
[TBL] [Abstract][Full Text] [Related]
12. Evaluation and study of antimicrobial activity of nanoliposomal meropenem against Pseudomonas aeruginosa isolates.
Zahra MJ; Hamed H; Mohammad RY; Nosratollah Z; Akbarzadeh A; Morteza M
Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):975-980. PubMed ID: 27322561
[TBL] [Abstract][Full Text] [Related]
13. The action of Pseudomonas aeruginosa biofilms in intrinsic drug resistance.
Xie Y; Jia WX; Zeng W; Yang WQ; Cheng X; Li XR; Wang LL; Kang M; Zhang ZR
Chin Med J (Engl); 2005 Oct; 118(19):1615-22. PubMed ID: 16232346
[TBL] [Abstract][Full Text] [Related]
14. Relationship between antibiotic resistance, biofilm formation, genes coding virulence factors and source of origin of
Ratajczak M; Kamińska D; Nowak-Malczewska DM; Schneider A; Dlugaszewska J
Ann Agric Environ Med; 2021 Jun; 28(2):306-313. PubMed ID: 34184515
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of blaGES-5 and bla veb-1 genes with multidrug-resistant extend, pandrug resistance patterns (MDR, XDR, PDR), and biofilm formation in Pseudomonas aeruginosa isolates.
Ali FA; Bakir SH; Haji SH; Hussen BM
Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):52-60. PubMed ID: 34933733
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of antimicrobial resistance, biofilm forming potential, and the presence of biofilm-related genes among clinical isolates of Pseudomonas aeruginosa.
Kamali E; Jamali A; Ardebili A; Ezadi F; Mohebbi A
BMC Res Notes; 2020 Jan; 13(1):27. PubMed ID: 31924268
[TBL] [Abstract][Full Text] [Related]
17. Interaction of biofilm and efflux pump in clinical isolates of carbapenem resistant P. aeruginosa.
Li XF; Shi HQ; Liang Y; Li J; Jiang B; Song GB
Eur Rev Med Pharmacol Sci; 2022 Mar; 26(5):1729-1737. PubMed ID: 35302222
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the anti-biofilm and antibacterial effects of Juglans regia L. extracts against clinical isolates of Pseudomonas aeruginosa.
Dolatabadi S; Moghadam HN; Mahdavi-Ourtakand M
Microb Pathog; 2018 May; 118():285-289. PubMed ID: 29605650
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of the oprD porin gene by a novel insertion sequence ISPa195 associated with large deletion in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate.
Bocharova Y; Savinova T; Shagin DA; Shelenkov AA; Mayanskiy NA; Chebotar IV
J Glob Antimicrob Resist; 2019 Jun; 17():309-311. PubMed ID: 30684654
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the Multidrug Efflux Pumps in Betalactams Resistant Pseudomonas aerugionsa Clinical Isolates Collected from Burn Patients in Iran.
Bijari A; Azimi L; Fallah F; Ardebili A; Lari ER; Lari AR
Infect Disord Drug Targets; 2016; 16(3):172-177. PubMed ID: 27572250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
